SEC Form 4 · Updated Daily
CRSP
— CRISPR Therapeutics Ltd OwnershipInsider and institutional ownership derived from SEC Form 4 filings. Click any owner to see their holdings across every company they’ve filed on, and how their position has changed over time.
Current Reporting Owners
| Owner | Role | Shares Owned | As Of | Last Activity |
|---|---|---|---|---|
| Kulkarni Samarth | Director · Officer | 255,501 | 2026-03-23 | S |
| KASINGER JAMES R. | Officer | 94,308 | 2026-03-23 | S |
| Patel Naimish | Officer | 19,357 | 2026-05-29 | S |
| Prasad Raju | Officer | 14,815 | 2026-08-07 | G |
Recent Filings
| Date | Owner | Activity | Shares | Price | Owned After |
|---|---|---|---|---|---|
| 2026-08-07 | Prasad Raju | Gift | 750 | $0.00 | 14,815 |
| 2026-06-05 | Treco Douglas A | Grant / award (derivative) | 13,000 | $0.00 | 13,000 |
| 2026-06-05 | Rommel Christian | Grant / award (derivative) | 13,000 | $0.00 | 13,000 |
| 2026-06-05 | Morrison Briggs | Grant / award (derivative) | 13,000 | $0.00 | 13,000 |
| 2026-06-05 | Mahatme Sandesh | Grant / award (derivative) | 13,000 | $0.00 | 13,000 |
| 2026-06-05 | High Katherine A | Grant / award (derivative) | 13,000 | $0.00 | 13,000 |
| 2026-06-05 | Greene John | Grant / award (derivative) | 13,000 | $0.00 | 13,000 |
| 2026-06-05 | Fleming Harold Edward | Grant / award (derivative) | 13,000 | $0.00 | 13,000 |
| 2026-06-05 | Fardis Maria | Grant / award (derivative) | 13,000 | $0.00 | 13,000 |
| 2026-06-05 | Behbahani Ali | Grant / award (derivative) | 13,000 | $0.00 | 13,000 |
| 2026-06-05 | George Simeon | Grant / award (derivative) | 13,000 | $0.00 | 13,000 |
| 2026-05-29 | Patel Naimish | Open-market sale | 3,786 | $55.62 | 19,357 |
| 2026-05-29 | Prasad Raju | Grant / award (derivative) | 19,500 | $0.00 | 19,500 |
| 2026-05-29 | Patel Naimish | Grant / award (derivative) | 22,000 | $0.00 | 22,000 |
| 2026-05-29 | KASINGER JAMES R. | Grant / award (derivative) | 17,000 | $0.00 | 17,000 |
| 2026-05-28 | Patel Naimish | Option exercise (derivative) | 10,000 | — | 20,000 |
| 2026-05-28 | Patel Naimish | Option exercise | 10,000 | — | 23,143 |
| 2026-03-23 | Prasad Raju | Open-market sale | 3,708 | $46.78 | 15,565 |
| 2026-03-23 | Kulkarni Samarth | Open-market sale | 10,020 | $46.78 | 255,501 |
| 2026-03-23 | KASINGER JAMES R. | Open-market sale | 3,182 | $46.78 | 94,308 |
| 2026-03-20 | Patel Naimish | Grant / award (derivative) | 30,000 | $0.00 | 30,000 |
| 2026-03-20 | Patel Naimish | Grant / award (derivative) | 38,499 | $0.00 | 38,499 |
| 2026-03-20 | Prasad Raju | Option exercise (derivative) | 6,250 | — | 12,500 |
| 2026-03-20 | Prasad Raju | Grant / award (derivative) | 27,500 | $0.00 | 27,500 |
| 2026-03-20 | Prasad Raju | Grant / award (derivative) | 38,499 | $0.00 | 38,499 |
| 2026-03-20 | Prasad Raju | Option exercise | 6,250 | — | 19,273 |
| 2026-03-20 | Kulkarni Samarth | Option exercise (derivative) | 19,687 | — | 39,375 |
| 2026-03-20 | Kulkarni Samarth | Grant / award (derivative) | 81,875 | $0.00 | 81,875 |
| 2026-03-20 | Kulkarni Samarth | Grant / award (derivative) | 114,249 | $0.00 | 114,249 |
| 2026-03-20 | Kulkarni Samarth | Option exercise | 19,687 | — | 265,521 |
| 2026-03-20 | KASINGER JAMES R. | Option exercise (derivative) | 6,250 | — | 12,000 |
| 2026-03-20 | KASINGER JAMES R. | Grant / award (derivative) | 25,000 | $0.00 | 25,000 |
| 2026-03-20 | KASINGER JAMES R. | Grant / award (derivative) | 38,499 | $0.00 | 38,499 |
| 2026-03-20 | KASINGER JAMES R. | Option exercise | 6,250 | — | 97,490 |
| 2026-03-16 | Kulkarni Samarth | Open-market sale | 10,349 | $48.26 | 245,834 |
| 2026-03-16 | KASINGER JAMES R. | Open-market sale | 3,450 | $48.26 | 91,240 |
| 2026-03-16 | Prasad Raju | Gift | 750 | $0.00 | 13,023 |
| 2026-03-16 | Prasad Raju | Open-market sale | 4,021 | $48.26 | 13,773 |
| 2026-03-16 | Prasad Raju | Open-market sale | 5,848 | $48.26 | 17,794 |
| 2026-03-16 | Patel Naimish | Open-market sale | 3,150 | $48.26 | 13,143 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.